These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1803236)

  • 1. In vitro activity of nitroxoline against clinical isolates of Candida species.
    Hernández Molina JM; Llosá J; Ventosa A
    Mycoses; 1991; 34(7-8):323-5. PubMed ID: 1803236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
    Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activity of nitroxoline against Candida auris isolates.
    Fuchs F; Hof H; Hofmann S; Kurzai O; Meis JF; Hamprecht A
    Clin Microbiol Infect; 2021 Nov; 27(11):1697.e7-1697.e10. PubMed ID: 34245904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro antifungal activity of nitroxoline. Preliminary clinical results].
    Cancet B; Amgar A
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):879-81. PubMed ID: 3309833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis.
    Mallié M; Montès B; Lebecq JC; Bastide JM
    Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
    Smith KR; Lank KM; Dismukes WE; Cobbs CG
    Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):588-92. PubMed ID: 1655435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
    Barchiesi F; Tortorano AM; Di Francesco LF; Cogliati M; Scalise G; Viviani MA
    J Antimicrob Chemother; 1999 Feb; 43(2):295-9. PubMed ID: 11252339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Fuchs F; Aldejohann AM; Hoffmann AM; Walther G; Kurzai O; Hamprecht AG
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0226521. PubMed ID: 35543103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antifungal activity of nitroxoline].
    Hernández JM; Llosá J; Martínez A
    Enferm Infecc Microbiol Clin; 1991; 9(7):439-40. PubMed ID: 1799618
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.
    Moody MR; Young VM; Morris MJ; Schimpff SC
    Antimicrob Agents Chemother; 1980 May; 17(5):871-5. PubMed ID: 6249197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
    Yamazumi T; Kuroda T; Ohata T; Obana Y; Furuta I
    Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Candida species strains to five antifungal agents: comparison between agar dilution and disk diffusion tests.
    Trancassini M; Ghezzi MC; Cipriani P; Mancini C; Brenciaglia MI
    Chemioterapia; 1986 Feb; 5(1):14-7. PubMed ID: 3955776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
    Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity of yeasts of the genus Candida to new antifungal agents].
    Hernández-Molina JM; Llosá J; Martínez-Brocal A; de la Rosa M
    Enferm Infecc Microbiol Clin; 1991; 9(7):405-8. PubMed ID: 1799609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro antifungal susceptibility studies with 30 serotype A and B isolates of Candida albicans.
    Shadomy S; Shadomy HJ
    Diagn Microbiol Infect Dis; 1991; 14(1):21-2. PubMed ID: 2013207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.